XAO 0.77% 8,209.2 all ordinaries

Short Term Trading Week Starting: 2nd Jan, page-53

  1. 35,472 Posts.
    lightbulb Created with Sketch. 2863
    Biggest total M&A deal of all time...worth posting everywhere lol.


    Given I'm a big Bio/Healthtech fan for 2019, it is a good start.

    I think Cynata - CYP will get a takeover bid 2019, and sooner I think.

    Couple main reasons.


    Even though Cynata are going into 2019 with 3x Phase 2 human trials planned...none of them are hostile to FujiFilm.

    1. GvHD is with fuji

    2. OA is Aust with grant via Uni Hospital Sydney

    3. CLI - Cyanta is going it alone (when they had it available for licence in June presentation)


    Not a single conflicting partner to get this far.


    they have at least 6 other targets lined up + one oncology 


    Then FujiFilm are on countdown clock now to exercise global option on CYP-001 (March 18th latest)

    They are building an industrialized cell manufacturing site USA in which they mention Cynata throughout announcement. (see CYP thread today)

    Finally, FujiFilm would need to licence also the manufacturing which also attracts "fees" 


    Cap is $130m (Fuji hold circa 9%)

    CYP-001 GvHD is worth $64m in upfronts and milestones plus double digit royalties. then add the manufacturing licence/fees.


    I am sure Fujifilm bean counters are just not that stupid!


    That's why I picked it in comp, as something has to give either way, and very soon.

    I am actually expecting a first move by end Jan. I don't think they wait the full 90 days.




 
watchlist Created with Sketch. Add XAO (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.